Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. (отвара нови прозор)

Abdelrazik N, Fouda M

Извор‎: Hematology 2007;12(6):533-41.

Индекс‎: PubMed 17852440

DOI‎: 10.1080/10245330701521572

https://www.ncbi.nlm.nih.gov/pubmed/17852440 (отвара нови прозор)

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. (отвара нови прозор)

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

Извор‎: Cancer 2012;118(3):848-55.

Индекс‎: PubMed 21751205

DOI‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 (отвара нови прозор)

Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment. (отвара нови прозор)

Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A

Извор‎: Pediatr Hematol Oncol 2008;25(6):509-21.

Индекс‎: PubMed 18728970

DOI‎: 10.1080/08880010802235132

https://www.ncbi.nlm.nih.gov/pubmed/18728970 (отвара нови прозор)

Recombinant human erythropoietin beta: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients. (отвара нови прозор)

Durmaz O, Demirkaya M, Sevinir B

Извор‎: Pediatr Hematol Oncol 2011;28(6):461-8.

Индекс‎: PubMed 21707225

DOI‎: 10.3109/08880018.2011.570857

https://www.ncbi.nlm.nih.gov/pubmed/21707225 (отвара нови прозор)

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. (отвара нови прозор)

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

Извор‎: J Clin Oncol 2010;28(13):2239-45.

Индекс‎: PubMed 20368566

DOI‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 (отвара нови прозор)

Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. (отвара нови прозор)

Hassan BA, Yusoff ZB

Извор‎: Asian Pac J Cancer Prev 2011;12(6):1573-6.

Индекс‎: PubMed 22126501

https://www.ncbi.nlm.nih.gov/pubmed/22126501 (отвара нови прозор)

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia. (отвара нови прозор)

Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K; ARANESP 20030232 Study Group

Извор‎: Curr Med Res Opin 2009;25(9):2109-20.

Индекс‎: PubMed 19601709

DOI‎: 10.1185/03007990903084164

https://www.ncbi.nlm.nih.gov/pubmed/19601709 (отвара нови прозор)

Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. (отвара нови прозор)

Hinds PS, Hockenberry M, Feusner J, Hord JD, Rackoff W, Rozzouk BI

Извор‎: J Support Oncol 2005;3(6 Suppl 4):10-1.

Индекс‎: PubMed 16355549

https://www.ncbi.nlm.nih.gov/pubmed/16355549 (отвара нови прозор)

The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer. (отвара нови прозор)

Hiradfar A, Banihosseinian M

Извор‎: Iran J Ped Hematol Oncol 2014;4(4):151-9.

Индекс‎: PubMed 25598955

https://www.ncbi.nlm.nih.gov/pubmed/25598955 (отвара нови прозор)

2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. (отвара нови прозор)

Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I.

Извор‎: Pediatr Blood Cancer 2009;53(1):7-12.

Индекс‎: PubMed 19229970

DOI‎: 10.1002/pbc.21953

https://www.ncbi.nlm.nih.gov/pubmed/19229970 (отвара нови прозор)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (отвара нови прозор)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Извор‎: Cancer 2013;119(1):107-14.

Индекс‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (отвара нови прозор)

Erythropoietic growth factors for children with cancer: a systematic review of the literature. (отвара нови прозор)

Mystakidou K, Potamianou A, Tsilika E

Извор‎: Curr Med Res Opin 2007;23(11):2841-7.

Индекс‎: PubMed 17910805

DOI‎: 10.1185/030079907x242601

https://www.ncbi.nlm.nih.gov/pubmed/17910805 (отвара нови прозор)

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. (отвара нови прозор)

Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR

Извор‎: J Clin Oncol 2006;24(22):3583-9.

Индекс‎: PubMed 16877725

DOI‎: 10.1200/JCO.2005.03.4371

https://www.ncbi.nlm.nih.gov/pubmed/16877725 (отвара нови прозор)

The role of recombinant erythropoietin in childhood cancer. (отвара нови прозор)

Shankar AG

Извор‎: Oncologist 2008;13(2):157-66.

Индекс‎: PubMed 18305061

DOI‎: 10.1634/theoncologist.2007-0126

https://www.ncbi.nlm.nih.gov/pubmed/18305061 (отвара нови прозор)

Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients. (отвара нови прозор)

Vargas A, Mendoza I, Uranga R, González A, Martínez L, Caballero I, Piedra P, Saurez G, Verdecia M, Cabanas R

Извор‎: MEDICC Rev 2010;12(3):27-31.

Индекс‎: PubMed 20697335

DOI‎: 10.37757/MR2010.V12.N3.7

https://www.ncbi.nlm.nih.gov/pubmed/20697335 (отвара нови прозор)

A single institutional experience: is epoetin alpha effective in anemic children with cancer? (отвара нови прозор)

Yilmaz D, Cetingül N, Kantar M, Oniz H, Kansoy S, Kavakli K

Извор‎: Pediatr Hematol Oncol 2004;21(1):1-8.

Индекс‎: PubMed 14660300

https://www.ncbi.nlm.nih.gov/pubmed/14660300 (отвара нови прозор)

Single dose darbepoetin alfa is useful in reducing red cell transfusions in leukemic children receiving chemotherapy. (отвара нови прозор)

Zachariah M, Elshinawy M, Alrawas A, Bashir W, Elbeshlawi I, Tony S, Wali Y

Извор‎: Pediatr Hematol Oncol 2014;31(5):442-7.

Индекс‎: PubMed 24088186

DOI‎: 10.3109/08880018.2013.824527

https://www.ncbi.nlm.nih.gov/pubmed/24088186 (отвара нови прозор)

Early epoetin alfa treatment in children with solid tumors. (отвара нови прозор)

Zoubek A, Kronberger M

Извор‎: Med Pediatr Oncol 2002;39(4):459-62.

Индекс‎: PubMed 12203664

DOI‎: 10.1002/mpo.10186

https://www.ncbi.nlm.nih.gov/pubmed/12203664 (отвара нови прозор)

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. (отвара нови прозор)

Crary SE, Hall K, Buchanan GR.

Извор‎: Pediatr Blood Cancer 2011;56(4):615-9.

Индекс‎: PubMed 21298748

DOI‎: 10.1002/pbc.22930

https://www.ncbi.nlm.nih.gov/pubmed/21298748 (отвара нови прозор)

Intravenous iron sucrose for children with iron deficiency anemia. (отвара нови прозор)

Kaneva K, Chow E, Rosenfield CG, Kelly MJ

Извор‎: J Pediatr Hematol Oncol 2017;39(5):e259-62.

Индекс‎: PubMed 28562517

DOI‎: 10.1097/MPH.0000000000000879

https://www.ncbi.nlm.nih.gov/pubmed/28562517 (отвара нови прозор)

Advances in Pediatric Intravenous Iron Therapy. (отвара нови прозор)

Mantadakis E.

Извор‎: Pediatr Blood Cancer 2016;63(1):11-6.

Индекс‎: PubMed 26376214

DOI‎: 10.1002/pbc.25752

https://www.ncbi.nlm.nih.gov/pubmed/26376214 (отвара нови прозор)

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. (отвара нови прозор)

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Извор‎: Cochrane Database Syst Rev 2016;(2):CD009624.

Индекс‎: PubMed 26845108

DOI‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 (отвара нови прозор)

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. (отвара нови прозор)

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

Извор‎: J Clin Oncol 2008;26(10):1619-25.

Индекс‎: PubMed 18375891

DOI‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 (отвара нови прозор)

Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. (отвара нови прозор)

Plummer ES, Crary SE, McCavit TL, Buchanan GR

Извор‎: Pediatr Blood Cancer 2013;60(11):1747-52.

Индекс‎: PubMed 23832487

DOI‎: 10.1002/pbc.24676

https://www.ncbi.nlm.nih.gov/pubmed/23832487 (отвара нови прозор)